Nohla Therapeutics
PrivateCompany Overview
Nohla Therapeutics is a biotechnology company that develops off-the-shelf, universal donor cellular therapies for patients with hematologic malignancies and other critical diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
cellular therapystem cell therapyoff-the-shelf therapyhematologic malignanciesumbilical cord bloodnotch ligand technologydilanubicelallogeneic transplantcell expansionneutropenia treatmentbiotechcell therapy manufacturingclinical-stage biotechregenerative medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nohla Therapeutics Comparables
Compare Nohla Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExCellThera | 82% | |
| Angiocrine Bioscience | 79% | |
| Gamida Cell Ltd. | 78% | |
Nohla Therapeutics Funding Rounds
Historical fundraising activity
Nohla Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nohla Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?